LCAT, HDL cholesterol and ischemic cardiovascular disease: A mendelian randomization study of HDL cholesterol in 54,500 individuals

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 2, 2012, Pages

  Haase, Christiane L ^a   Tybjærg Hansen, Anne ^a,b   Ali Qayyum, Abbas ^a   Schou, Jesper ^a   Nordestgaard, Børge G ^b   Frikke Schmidt, Ruth ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LECITHIN CHOLESTEROL ACYLTRANSFERASE GENE; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES; YOUNG ADULT;

EID: 84856786437     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1846     Document Type: Article

References (40)

1. Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J 2009 Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993-2000
2. Vergeer M, Holleboom AG, Kastelein JJ, Kuivenhoven JA 2010 The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 51:2058-2073
3. Hausenloy DJ, Yellon DM 2008 Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart 94:706-714 (Pubitemid 351744686)
4. Wild S, Byrne CD 2008 Time to rethink high-density lipoprotein? Heart 94:692-694 (Pubitemid 351744684)
5. Rader DJ 2009 Lecithin:cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script. Circulation 120:549-552
6. Frikke-Schmidt R, Nordestgaard BG, Stene MC Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjaerg-Hansen A 2008 Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 299:2524-2532 (Pubitemid 351787208)
7. Frikke-Schmidt R 2010 Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population. Atherosclerosis 208:305-316
8. Nordestgaard BG, Tybjærg-Hansen A 2011 Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk. Curr Opin Lipidol 22:113-122
9. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, et al. 2010 Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707-713
10. Davey Smith G, Ebrahim S 2003 "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1-22 (Pubitemid 36503465)
11. Haase CL, Frikke-Schmidt R, Nordestgaard BG, Kateifides AK, Kardassis D, Nielsen LB, Andersen CB, Køber L, Johnsen AH, Grande P, Zannis VI, Tybjaerg-Hansen A 2011 Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels. J Intern Med 270:136-146
12. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
13. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, DeBacker G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG) 2006 Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27:1341-1381 (Pubitemid 43998110)
14. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction 2007 Universal definition of myocardial infarction. Eur Heart J 28:2525-2538
15. Nørskov MS, Frikke-Schmidt R, Loft S, Sillesen H, Grande P, Nordestgaard BG, Tybjaerg-Hansen A 2011 Copy number variation in glutathione s-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses. Circ Cardiovasc Genet 4:418-428
16. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R 1999 Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150:341-353 (Pubitemid 29383482)
17. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G 2008 Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133-1163 (Pubitemid 351395448)
18. Altman DG, Bland JM 2003 Interaction revisited: the difference between two estimates. BMJ 326:219 (Pubitemid 36143396)
19. McLean J, Fielding C, Drayna D, Dieplinger H, Baer B, Kohr W, Henzel W, Lawn R 1986 Cloning and expression of human lecithin-cholesterol acyltransferase cDNA. Proc Natl Acad Sci USA 83:2335-2339 (Pubitemid 16026881)
20. Hoppe KL, Francone OL 1998 Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin: cholesterol acyltransferase promoter. J Lipid Res 39:969-977 (Pubitemid 28222001)
21. Santamarina-Fojo S, Hoeg J, Assmann G, Brewer Jr HB 2001 Lecithin cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2817-28133
22. Johannsen TH, Kamstrup PR, Andersen RV, Jensen GB, Sillesen H, Tybjaerg-Hansen A, Nordestgaard BG 2009 Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. J Clin Endocrinol Metab 94:1264-1273
23. Haase CL, Tybjærg-Hansen A, Grande P, Frikke-Schmidt R 2010 Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease. J Clin Endocrinol Metab 95:E500-E510
24. Jensen MK, Rimm EB, Mukamal KJ, Edmondson AC, Rader DJ, Vogel U, Tjønneland A, Sørensen TI, Schmidt EB, Overvad K 2009 The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J 30:1584-1589
25. Hokanson JE, Cheng S, Snell-Bergeon JK, Fijal BA, Grow MA, Hung C, Erlich HA, Ehrlich J, Eckel RH, Rewers M 2002 A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes 51:1208-1213 (Pubitemid 34438370)
26. Mahley RW, Rall Jr SC 2001 Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2835-2862
27. Austin MA, McKnight B, Edwards KL, Bradley CM, McNeely MJ, Psaty BM, Brunzell JD, Motulsky AG 2000 Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 101:2777-2782 (Pubitemid 30396006)
28. Nestel PJ, Fidge NH, Tan MH 1982 Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 307:329-333 (Pubitemid 12082192)
29. Kasama T, Yoshino G, Iwatani I, Iwai M, Hatanaka H, Kazumi T, Oimomi M, Baba S 1987 Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics. Atherosclerosis 63:263-266 (Pubitemid 17232760)
30. Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A 1997 Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 96:1737-1744 (Pubitemid 27400727)
31. Franceschini G, Sirtori CR, Capurso 2nd A, Weisgraber KH, Mahley RW 1980 A-I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 66:892-900 (Pubitemid 11233787)
32. Hovingh GK, Hutten BA, Holleboom AG, Petersen W, Rol P, Stalenhoef A, Zwinderman AH, de Groot E, Kastelein JJ, Kuivenhoven JA 2005 Compromised LCAT function is associated with increased atherosclerosis. Circulation 112:879-884 (Pubitemid 41170075)
33. Calabresi L, Baldassarre D, Castelnuovo S, Conca P, Bocchi L, Candini C, Frigerio B, Amato M, Sirtori CR, Alessandrini P, Arca M, Boscutti G, Cattin L, Gesualdo L, Sampietro T, Vaudo G, Veglia F, Calandra S, Franceschini G 2009 Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120:628-635
34. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH 2004 Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869-872 (Pubitemid 39038422)
35. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjærg-Hansen A 2004 Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 1141343-1353
36. Kuivenhoven JA, Weibusch H, Pritchard PH, Funke H, Benne R, Assmann G, Kastelein JJ 1996 An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest 98:358-364 (Pubitemid 26255734)
37. Kuivenhoven JA, van Voorst tot Voorst EJ, Wiebusch H, Marcovina SM, Funke H, Assmann G, Pritchard PH, Kastelein JJ 1995 A unique genetic and biochemical presentation of fish-eye disease. J Clin Invest 96:2783-2791
38. Kuivenhoven JA, Stalenhoef AF, Hill JS, Demacker PN, Errami A, Kastelein JJ, Pritchard PH 1996 Two novel molecular defects in the LCAT gene are associated with fish eye disease. Arterioscler Thromb Vasc Biol 16:294-303 (Pubitemid 26056250)
39. Daniil G, Phedonos AA, Holleboom AG, Motazacker MM, Argyri L, Kuivenhoven JA, Chroni A 2011 Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders. Clin Chim Acta 412:1213-1220
40. Goyal J, Wang K, Liu M, Subbaiah PV 1997 Novel function of lecithin-cholesterol acyltransferase. J Biol Chem 272:16231-16239